Intravenous (IV) Lidocaine for Opioid-refractory Pain
Status:
Withdrawn
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Opioid medicines, like morphine, are the main treatment for severe cancer pain.
Unfortunately, some patients suffer severe pain despite high doses of opioids. We hypothesize
that intravenous lidocaine can quickly and effectively treat this kind of opioid-refractory
pain.